Search Tag: cardiotoxicity

Cardiology Management

Onco-Cardiology: Consensus Paper from Germany

2020 27 May

There is sufficient clinical evidence to show that the use of certain chemotherapeutic drugs is associated with cardiac toxicity. In many cases, the impairment in cardiac dysfunction caused by these drugs is lifelong and can severely impair the quality of life of patients. While many drugs continue to be approved to treat malignancies, the cardiac... Read more

Cardiology Management

CARDIOTOXIC Study: Relationship Between Cancer Therapy and CVD

2020 12 Feb

Certain classes of anticancer drugs are cardiotoxic, especially the anthracycline group of chemotherapeutic agents. In most cases, the cardiotoxic effect of these agents comes to light when the patient undergoes surgery for cancer and then develops heart failure, arrhythmias or dies. Most oncologists and surgeons make it a point to ensure that patients... Read more

Cardiology Management

Urgent need to look after hearts of cancer patients

2019 08 May

Many physicians are not telling cancer patients about the cardiotoxicity risks of treatments and may not be fully aware of the dangers themselves. A new study reveals an urgent need to look after the hearts of these patients. The research is presented today at EuroHeartCare 2019. "There was no mention that it could lead to heart disease. Would... Read more

Cardiology Management

Developing 'Best Practice' in Cardio-oncology

2017 20 Jun

Cardiovascular toxicity has become a challenging issue during cancer therapy. A survey of oncologists in France reveals that respondents commonly (>90%) prescribe therapies that are associated with cardiotoxicity. Interestingly, the survey shows that the assessment and management of the cardiovascular status of cancer patients is often inconsistent... Read more